SCHEMBL2243379

SCHEMBL2243379

COn1cc(CCN)c2ccccc21

nearest known ligand 0.63

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.63
HTR6 P50406 15/20 0.51
SCN9A Q15858 1/20 0.50
TAAR1 Q96RJ0 1/20 0.43
ADRB2 P07550 1/20 0.43
OPRM1 P35372 1/20 0.41
OPRK1 P41145 1/20 0.41
OPRL1 P41146 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28126599 0.98 HTR2A (0.61) HTR2AHTR6SCN9ATAAR1ADRB2
Methyl Carbamate SCHEMBL6828082 0.90 HTR2A (0.52) HTR2AHTR6SCN9A
SCHEMBL27174180 0.84 HTR2A (0.59) HTR2AHTR6SCN9AOPRM1OPRK1
SCHEMBL9210349 0.82 HTR6 (0.60) HTR2AHTR6SCN9ATAAR1ADRB2
SCHEMBL20855303 0.81 GPR84 (0.43) HTR2ASCN9AOPRM1OPRL1
SCHEMBL10064695 0.81 GPR84 (0.43) HTR2A
SCHEMBL7500287 0.81 HTR6 (0.57) HTR6
SCHEMBL21333617 0.81 HTR2A (0.55) HTR2AHTR6SCN9A
SCHEMBL25345505 0.80 HTR2A (0.55) HTR2AHTR6SCN9A
SCHEMBL26185613 0.80 HTR2A (0.54) HTR2AHTR6SCN9AOPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 203 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118291286-A Yarrowia lipolytica engineering bacterium for synthesizing N-acetyl-5 methoxy tryptamine by taking tryptophan as substrate, construction and application thereof 河北维达康生物科技有限公司 2024-07-05 CN claimed
CN-118020575-A Planting method of traditional Chinese medicine baical skullcap root in saline-alkali soil 中国科学院遗传与发育生物学研究所农业资源研究中心 2024-05-14 CN claimed
CN-117625517-A Zebra fish embryo culture solution for detecting efficacy of cosmetics and application thereof 福建中妆技术研究有限公司 2024-03-01 CN claimed
CN-117343854-A Yarrowia lipolytica engineering bacterium for synthesizing N-acetyl-5 methoxy tryptamine by using 5-hydroxytryptophan as substrate and application thereof 河北维达康生物科技有限公司 2024-01-05 CN claimed
CN-115364283-A Bionic interface multilayer composite nerve scaffold and preparation method and application thereof 上海市第六人民医院 2022-11-22 CN claimed
CN-112195151-B Dental pulp mesenchymal stem cell recovery culture solution, preparation method and recovery culture method 范德里希(上海)生物科技有限公司 2022-06-21 CN claimed
EP-4003274-A1 COSMETIC COMPOSITIONS COMPRISING PLANT EXTRACTS AND USES THEREOF Alumier Europe Limited (MT) 2022-06-01 EP claimed
WO-2021013973-A1 COSMETIC COMPOSITIONS COMPRISING PLANT EXTRACTS AND USES THEREOF ALUMIER EUROPE LIMITED (MT) 2021-01-28 WO claimed
CN-112195151-A Dental pulp mesenchymal stem cell recovery culture solution, preparation method and recovery culture method 夏爽 2021-01-08 CN claimed
CN-106317187-B Five methoxytryptamine base carbonyl propionyl-PAK peptides, preparation, activity and application 首都医科大学 2019-07-12 CN claimed
EP-1476152-A4 USE OF MELATONIN ANALOGUES FOR INDUCTION OF GENERAL ANESTHESIA UNIV IOWA RES FOUND (US) 2007-04-11 EP claimed
CN-1708331-A Preparation containing melatonin, semen Ginkgo and biotin ASAT AG APPLIED SCIENCE & TECH (CH) 2005-12-14 CN claimed
EP-1476152-A2 USE OF MELATONIN ANALOGUES FOR INDUCTION OF GENERAL ANESTHESIA University of Iowa Research Foundation (US) 2004-11-17 EP claimed
US-20040022822-A1 Cosmetic compositions containing keratinization modulators and methods for improving keratinous surfaces REVLON CONSUMER PRODUCTS CORPORATION (US) 2004-02-05 US claimed
WO-2003070177-A2 USE OF MELATONIN ANALOGUES FOR INDUCTION OF GENERAL ANESTHESIA UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2003-08-28 WO claimed
EP-1212056-A1 METHODS AND COMPOSITIONS FOR BISUBSTRATE INHIBITORS OF ACETYLTRANSFERASES The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services (US) 2002-06-12 EP claimed
US-20020034524-A1 Cosmetic compositions containing keratinization modulators and methods for improving keratinous surfaces REVLON CONSUMER PRODUCTS CORPORATION 2002-03-21 US claimed
WO-2002000176-A1 COSMETIC COMPOSITIONS CONTAINING KERATINIZATION MODULATORS AND METHODS FOR IMPROVING KERATINOUS SURFACES REVLON CONSUMER PRODUCTS CORPORATION (US) 2002-01-03 WO claimed
WO-2001012185-A1 METHODS AND COMPOSITIONS FOR BISUBSTRATE INHIBITORS OF ACETYLTRANSFERASES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2001-02-22 WO claimed
US-4428880-A Azepino[4,5-d]indole derivatives and preparation thereof S.A. OMNICHEM (BE) 1984-01-31 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020034524-A1 Cosmetic compositions containing keratinization modulators and methods for improving keratinous surfaces KRT18, MC1R, HTR6 HTR2A 7/4885HTR6 3/4885SCN9A 3402/4885
US-20040022822-A1 Cosmetic compositions containing keratinization modulators and methods for improving keratinous surfaces KRT18, MC1R, HTR6 HTR2A 7/4885HTR6 3/4885SCN9A 3402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.